MitoImmune Therapeutics is Biotechnology in South Korea that focus on development biotech company business. Founded in 2018. They cover business area such as drug discovery, mitochondria, its proprietary technology, treatment, patient, their life.
2018
( 6 years old in 2024 )
Development Biotech Company
-
Glaston Building 13th Floor
108 Bongeunsa-ro, Yeoksam-dong
Seoul, Gangnam-gu 06253
South Korea
Private
drug discoverymitochondriaits proprietary technologytreatmentpatienttheir life
* We use standard office opening hours in near MitoImmune Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MitoImmune Therapeutics is Biotechnology business from South Korea that founded in 2018 (6 years old in 2024), MitoImmune Therapeutics business is focusing on Development Biotech Company.
MitoImmune Therapeutics headquarter office and corporate office address is located in Glaston Building 13th Floor 108 Bongeunsa-ro, Yeoksam-dong Seoul, Gangnam-gu 06253 South Korea.
MitoImmune Therapeutics was founded in South Korea.
In 2024, MitoImmune Therapeutics is currently focus on development biotech company sector.
Above is snippet of Google Trends for "development biotech company" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MitoImmune Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
